Cargando…
Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285922/ https://www.ncbi.nlm.nih.gov/pubmed/34285480 http://dx.doi.org/10.2147/COPD.S275943 |
_version_ | 1783723643000324096 |
---|---|
author | López-Campos, Jose Luis Carrasco Hernández, Laura Ruiz-Duque, Borja Reinoso-Arija, Rocio Caballero-Eraso, Candelaria |
author_facet | López-Campos, Jose Luis Carrasco Hernández, Laura Ruiz-Duque, Borja Reinoso-Arija, Rocio Caballero-Eraso, Candelaria |
author_sort | López-Campos, Jose Luis |
collection | PubMed |
description | Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options for each clinical context. As COPD is a chronic progressive disease, the escalation of therapy has traditionally been considered the most natural way to tackle it. However, the notion of COPD as a constantly progressing disease has recently been challenged and, in specific areas, this points to the possibility of a de-escalation in treatment. In this context, the clinician requires simple, specific recommendations to guide these changes in treatment in their daily clinical practice. To accomplish this, the first step must be a correct evaluation and an accurate initial preliminary diagnosis of the patient’s condition. Thereafter, the first escalation in therapy must be introduced with caution as the disease progresses, since clinical trials are not designed with clinical decision-making in mind. During this escalation, three possibilities are open to change the current treatment for a different one within the same family, to increase non-pharmacological interventions or to increase the pharmacological therapies. Beyond that point, a patient with persistent symptoms represents a complex clinical scenario which requires a specialized approach, including the evaluation of different respiratory and non-respiratory comorbidities. Unfortunately, there are few de-escalation studies available, and these are mainly observational in nature. The debate on de-escalation in pharmacological treatment, therefore, involves two main discussion points: the withdrawal of bronchodilators and the withdrawal of inhaled steroids. Altogether, the scheme for modifying treatment must be more personalized than just adding molecules, and the therapeutic response and its conditioning factors should be evaluated at each step before proceeding further. |
format | Online Article Text |
id | pubmed-8285922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82859222021-07-19 Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies López-Campos, Jose Luis Carrasco Hernández, Laura Ruiz-Duque, Borja Reinoso-Arija, Rocio Caballero-Eraso, Candelaria Int J Chron Obstruct Pulmon Dis Review Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options for each clinical context. As COPD is a chronic progressive disease, the escalation of therapy has traditionally been considered the most natural way to tackle it. However, the notion of COPD as a constantly progressing disease has recently been challenged and, in specific areas, this points to the possibility of a de-escalation in treatment. In this context, the clinician requires simple, specific recommendations to guide these changes in treatment in their daily clinical practice. To accomplish this, the first step must be a correct evaluation and an accurate initial preliminary diagnosis of the patient’s condition. Thereafter, the first escalation in therapy must be introduced with caution as the disease progresses, since clinical trials are not designed with clinical decision-making in mind. During this escalation, three possibilities are open to change the current treatment for a different one within the same family, to increase non-pharmacological interventions or to increase the pharmacological therapies. Beyond that point, a patient with persistent symptoms represents a complex clinical scenario which requires a specialized approach, including the evaluation of different respiratory and non-respiratory comorbidities. Unfortunately, there are few de-escalation studies available, and these are mainly observational in nature. The debate on de-escalation in pharmacological treatment, therefore, involves two main discussion points: the withdrawal of bronchodilators and the withdrawal of inhaled steroids. Altogether, the scheme for modifying treatment must be more personalized than just adding molecules, and the therapeutic response and its conditioning factors should be evaluated at each step before proceeding further. Dove 2021-07-12 /pmc/articles/PMC8285922/ /pubmed/34285480 http://dx.doi.org/10.2147/COPD.S275943 Text en © 2021 López-Campos et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review López-Campos, Jose Luis Carrasco Hernández, Laura Ruiz-Duque, Borja Reinoso-Arija, Rocio Caballero-Eraso, Candelaria Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies |
title | Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies |
title_full | Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies |
title_fullStr | Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies |
title_full_unstemmed | Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies |
title_short | Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies |
title_sort | step-up and step-down treatment approaches for copd: a holistic view of progressive therapies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285922/ https://www.ncbi.nlm.nih.gov/pubmed/34285480 http://dx.doi.org/10.2147/COPD.S275943 |
work_keys_str_mv | AT lopezcamposjoseluis stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies AT carrascohernandezlaura stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies AT ruizduqueborja stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies AT reinosoarijarocio stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies AT caballeroerasocandelaria stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies |